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T
hough all cells within an organism 
carry the same set of genes, they 
display a wide range of character-
istics, depending on where they are in the 
body and where the organism is in its life 
cycle. Howard Chang is interested in how 
large-scale gene regulatory programs con-
trol a cell’s behavior in space and time.
A practicing dermatologist, Chang stud-
ies many of these questions in the skin. After 
investigating apoptotic signaling mecha-
nisms for his PhD with David Baltimore at 
MIT (1), Chang joined Pat Brown’s labora-
tory for his postdoc, where he discovered 
that dermal fi  broblasts have markedly dif-
ferent gene expression patterns depending 
on their anatomical position (2). In his own 
lab at Stanford University, Chang has found 
that this positional identity partly relies 
upon long, noncoding RNAs that direct 
chromatin-modifying proteins to control the 
expression of HOX genes (3, 4). Inappropri-
ate expression of these RNAs can lead to dis-
eases such as breast cancer (5). Chang’s lab 
has also used gene expression profi  ling to 
reveal some of the molecular 
mechanisms underlying tum-
origenesis (6) and aging (7).
In a recent interview, 
Chang discussed how he ar-
rived at his current position 
and the future program of 
his research.
EARLY IDENTITY
Where did you grow up?
I was born in Taipei, Taiwan, 
but my family moved to southern Califor-
nia when I was 12. During high school, my 
biology teacher helped me get involved 
with a research project on organ transplan-
tation at the local university, UC Irvine, and 
I became really interested in how immuno-
suppressant drugs work. So from fairly 
early on, I was pretty sure that I wanted to 
be involved in research. But I was always 
interested in questions that relate to human 
health, so an MD-PhD program seemed 
like the best plan for me.
Why did you choose David Baltimore’s 
lab for your PhD?
The Baltimore lab was a really exciting 
place to be because people were studying 
lots of different questions using a wide 
variety of techniques. The philosophy 
there was to make a multipronged attack 
on whatever biological problem people 
wanted to solve. I was really attracted to that 
style. At the time, the mechanisms of pro-
grammed cell death were just beginning to 
be deciphered. So I got involved in a project 
to understand how certain cell surface 
“death” receptors could trigger apoptosis.
After ﬁ  nishing your MD, why did you join 
Pat Brown’s lab for your postdoc?
Pat was a pioneer of microarray technology 
and functional genomics. That was very dif-
ferent from what I’d done before. But I’d 
read one of his early papers in a journal club 
class during graduate school, and I thought 
it was a really exciting technology. I really 
appreciate the fact that Pat took me into his 
lab, because I wanted to do my clinical train-
ing and my postdoc at the 
same time. He wasn’t fazed 
when I told him that I’d be 
working very irregular hours 
or that he might not see me 
for months at a time.
One of the early questions 
we thought about was whether 
we could investigate the mech-
anisms of aging by looking at 
gene expression patterns in tis-
sues from people of different 
ages. Because I was training as a dermatol-
ogy resident, I decided to do this in skin. In 
the literature, a frequent source of primary 
human fibroblasts is neonatal foreskin, 
whereas cells from older persons are usually 
from the arm or somewhere other than the 
foreskin. So I thought I should do a control 
experiment to show that the anatomic site 
didn’t matter, and then I could go on to com-
pare the different ages. I arranged to get fi  bro-
blasts from different anatomical sites of the 
same person and the results were the exact 
opposite of what I was expecting—fi  bro-
blasts from different body sites showed dif-
ferent gene expression patterns. It was so 
interesting that working on the positional 
identity of cells within tissues quickly be-
came the main focus of my research.
POSITIONING SYSTEMS
How do cells know where they are in 
the body, and why investigate this 
question in skin?
Skin is a fantastic system because, in many 
animals, including humans, there are lots of 
site-specifi   c features that have important 
functions. For example, many of us have 
long hairs on our scalps but no hair on our 
palms and soles. Skin is also constantly 
regenerating—in humans, the epidermis 
turns over every 28 days—but the new cells 
carry information about their location in 
the body. We believe that much of this po-
sitional information can be traced back to 
the embryonic patterning mechanisms—
the HOX genes—which tell cells where 
they are along the different axes of the 
body. Although primary human fi  bro  blasts 
look very generic, we’ve found that they 
are actually quite different, depending on 
where they come from in the body. 
These differences are strongly associated 
with the specifi   c HOX genes that they 
continue to express, helping the cells to 
maintain a positional memory over time.
How did you end up working on 
noncoding RNAs?
HOX genes are organized into clusters of 
nine to eleven genes in a row. We wanted to 
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Chang studies how large groups of genes work together to carry out 
biological processes.
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“[This is] 
broadening 
the repertoire 
of how 
lncRNAs can 
regulate 
genes.”
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examine these loci at high resolution, look-
ing at all the expressed RNAs and at the 
different chromatin states associated with 
this expression, so we built a device called 
a tiling array. We were surprised to notice 
that, in addition to the HOX genes them-
selves, there were a lot of additional inter-
genic transcripts, many of which turned out 
to be what people now call long noncoding 
RNAs, or lncRNAs. They’re actually the 
dominant transcriptional output of the HOX 
loci, and they also show very nice position-
specifi  c patterns of expression.
That led us to ask what the function of 
these RNAs might be. lncRNAs involved 
in dosage compensation or genomic im-
printing tend to silence nearby genes. We 
depleted a HOX lncRNA called HOTAIR 
and saw that certain HOX genes were 
derepressed, but those genes were actually 
on other chromosomes. More recently, 
we’ve looked at an RNA called HOTTIP. 
This lncRNA creates a chromatin state 
that activates gene expression. So these 
examples are broadening the repertoire of 
how lncRNAs can regulate genes.
How do these lncRNAs contribute to 
human disease?
That’s something we’re really interested 
in. For example, we found that HOTAIR 
silences HOX genes by target-
ing the chromatin-remodeling 
Polycomb complex to them. 
Overexpression of Polycomb 
complex proteins can drive 
cancer progression, so we 
wondered whether HOTAIR 
itself could also be involved in 
tumorigenesis. Several years 
ago we looked at HOX non-
coding RNAs in human can-
cer samples and found that 
HOTAIR is very highly expressed in breast 
cancers that go on to metastasize or kill 
the patient. HOTAIR is a powerful predic-
tor of clinical outcome, and it actually 
drives cancer progression. So a project 
that started with a basic curiosity about 
skin patterning may have some important 
medical implications. More recently, we 
found a family of cell cycle–regulated 
lncRNAs, which are also dysregulated in 
human cancers.
GROUP DYNAMICS
You’ve done a lot of gene expression 
proﬁ  ling on tumor samples. How does 
that approach aid cancer research?
Many people in the fi  eld use expression 
profi  ling to create molecular snapshots of 
cancer or other disease processes. When I 
started my lab, I wanted to take these descrip-
tions and turn them into an understanding 
of causality. If hundreds of genes are chang-
ing, are there key individual switches that 
cause those genes to go up or down?
We developed computational methods 
and other strategies to defi  ne factors coor-
dinating the activities of large groups of 
genes. That information can be valuable in 
several ways. It provides insight into dis-
ease mechanisms, and it’s possible that you 
can track these regulators as markers of the 
disease rather than having to measure the 
activity of hundreds of genes. More impor-
tantly, maybe we can manipulate these 
master switches to create better disease 
models or even block the disease process.
You’ve also returned to the study of aging. 
What have you found out?
We started by examining changes in gene 
expression patterns that occur with aging 
and then looked for regulators that might be 
causing these changes. We realized that ag-
ing is associated with overac-
tivity of the stress-inducible 
transcription factor NF-   B . 
We removed NF-   B  from the 
skin of old mice and saw 
something very interesting: 
the skin cells started behaving 
as if they were young. As I 
mentioned before, the skin is 
constantly turning over, so it's 
always been curious that new 
skin cells born in an old person 
behave as if they’re old. So we think that 
NF-   B  is part of an active mechanism that 
tells cells to behave “old.” This project got 
a lot of attention in the lay press!
What is your lab working on now?
The questions we’re working on have the 
broad theme of how large groups of genes 
work together to carry out a biological pro-
gram. One current focus is on lncRNAs. Work 
from many groups, including our own, sug-
gests that there are thousands of these long 
RNAs in the genome, but how they perform 
their functions is still mysterious—it remains 
to be seen if there are any systematic rules.
The biological contexts of our studies 
remain cancer, aging, and lineage identity. 
We’re currently collaborating with Marius 
Wernig’s group to look at what happens 
when fi  broblasts are reprogrammed into 
other cell types. We started with the question 
of how fi  broblasts maintain positional infor-
mation over time. Studying reprogramming 
is an interesting way to probe the same ques-
tion: what aspects of positional memory 
have to be overcome to change cell fate?
How does being a practicing physician 
inﬂ  uence your research?
In the clinic, one sees many phenomena 
that trigger interesting questions. Even my 
original postdoc project was partly inspired 
by what I was learning in my clinical train-
ing. In dermatology, where a lesion occurs 
on the body makes a huge difference, but I 
realized that the molecular basis of this 
wasn’t understood. So I felt that investi-
gating whether fi  broblasts from different 
locations were identical was an important 
problem. I think these kinds of opportunities 
will continue to arise in the future.
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“In the 
clinic, one 
sees many 
phenomena 
that trigger 
interesting 
questions.”
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lncRNAs like HOTAIR regulate the expression of 
genes that tell cells where they are in the body.